These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 28273820)

  • 21. Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit.
    Suzuki H; Utsunomiya I; Shudo K; Fukuhara N; Iwaki T; Yasukata T
    Eur J Med Chem; 2013 May; 63():811-25. PubMed ID: 23584544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of varied substituents on the antibacterial activity of triazolylmethyl oxazolidinones.
    Phillips OA; Udo EE; Abdel-Hamid ME; Varghese R
    Arch Pharm (Weinheim); 2012 Oct; 345(10):790-803. PubMed ID: 22886578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action.
    Hubschwerlen C; Specklin JL; Baeschlin DK; Borer Y; Haefeli S; Sigwalt C; Schroeder S; Locher HH
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4229-33. PubMed ID: 14623007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor.
    Park HS; Yoon YM; Jung SJ; Kim CM; Kim JM; Kwak JH
    J Antimicrob Chemother; 2007 Sep; 60(3):568-74. PubMed ID: 17606482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antibacterial evaluation of isoxazolinyl oxazolidinones: Search for potent antibacterial.
    Varshney V; Mishra NN; Shukla PK; Sahu DP
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3573-6. PubMed ID: 19447611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus.
    Kim TS; Choe JH; Kim YJ; Yang CS; Kwon HJ; Jeong J; Kim G; Park DE; Jo EK; Cho YL; Jang J
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674049
    [No Abstract]   [Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of spiropyrimidinetriones oxazolidinone derivatives as antibacterial agents.
    Siddiqui AM; Sattigeri JA; Javed K; Shafi S; Shamim M; Singhal S; Malik ZM
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1198-1206. PubMed ID: 29525219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antibacterial activity of pyrroloaryl-substituted oxazolidinones.
    Paget SD; Foleno BD; Boggs CM; Goldschmidt RM; Hlasta DJ; Weidner-Wells MA; Werblood HM; Wira E; Bush K; Macielag MJ
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4173-7. PubMed ID: 14622996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction.
    Ji C; Lin W; Moraski GC; Thanassi JA; Pucci MJ; Franzblau SG; Möllmann U; Miller MJ
    Bioorg Med Chem; 2012 Jun; 20(11):3422-8. PubMed ID: 22560837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.
    Rolston K; Wang W; Nesher L; Coyle E; Shelburne S; Prince RA
    J Antibiot (Tokyo); 2014 Jul; 67(7):505-9. PubMed ID: 24824818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics, Pharmacodynamics, and Tolerability of Single-Dose Oral LCB01-0371, a Novel Oxazolidinone with Broad-Spectrum Activity, in Healthy Volunteers.
    Cho YS; Lim HS; Lee SH; Cho YL; Nam HS; Bae KS
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of novel oxazolidinone antimicrobial agents.
    Ebner DC; Culhane JC; Winkelman TN; Haustein MD; Ditty JL; Ippoliti JT
    Bioorg Med Chem; 2008 Mar; 16(5):2651-6. PubMed ID: 18077175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
    Zurenko GE; Yagi BH; Schaadt RD; Allison JW; Kilburn JO; Glickman SE; Hutchinson DK; Barbachyn MR; Brickner SJ
    Antimicrob Agents Chemother; 1996 Apr; 40(4):839-45. PubMed ID: 8849237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linezolid activity against clinical Gram-positive cocci with advanced antimicrobial drug resistance in Iran.
    Houri H; Kazemian H; Sedigh Ebrahim-Saraie H; Taji A; Tayebi Z; Heidari H
    J Glob Antimicrob Resist; 2017 Sep; 10():200-203. PubMed ID: 28735054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges.
    Brown SD; Traczewski MM
    Antimicrob Agents Chemother; 2010 May; 54(5):2063-9. PubMed ID: 20231392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-antibacterial activity of arylcarbonyl- and arylsulfonyl-piperazine 5-triazolylmethyl oxazolidinones.
    Phillips OA; Udo EE; Ali AA; Samuel SM
    Eur J Med Chem; 2007 Feb; 42(2):214-25. PubMed ID: 17140706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Derivatives of aryl-4-guanidinomethylbenzoate and N-aryl-4-guanidinomethylbenzamide as new antibacterial agents: synthesis and bioactivity.
    Yu WY; Yang LX; Xie JS; Zhou L; Jiang XY; Zhu DX; Muramatsu M; Wang MW
    Acta Pharmacol Sin; 2008 Feb; 29(2):267-77. PubMed ID: 18215358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of linezolid against Gram-positive uropathogens of hospitalized patients with complicated urinary tract infections.
    Onda H; Wagenlehner FM; Lehn N; Naber KG
    Int J Antimicrob Agents; 2001 Sep; 18(3):263-6. PubMed ID: 11673040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial activity of YC-20, a new oxazolidinone.
    Cui Y; Dang Y; Yang Y; Zhang S; Ji R
    J Antimicrob Chemother; 2006 Aug; 58(2):452-4. PubMed ID: 16807251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent.
    Takhi M; Murugan C; Munikumar M; Bhaskarreddy KM; Singh G; Sreenivas K; Sitaramkumar M; Selvakumar N; Das J; Trehan S; Iqbal J
    Bioorg Med Chem Lett; 2006 May; 16(9):2391-5. PubMed ID: 16488606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.